Top 5 Infectious Disease News Highlights (Nov 16-22): Essential Updates & Insights

Oral Vancomycin Reduces CDI by 64% in Stem Cell Transplant Patients

A recent study shows that oral vancomycin prophylaxis (OVP) lowers Clostridioides difficile infection (CDI) rates in autologous stem cell transplant (ASCT) patients during hospital stays. The study tracked 254 ASCT patients from January 2012 to December 2021. Those who received OVP (125 mg twice daily) had a 4% CDI rate compared to 11% in those who did not receive OVP, yielding a p-value of 0.03. The study found no increase in CDI risk during 180 days post-discharge. It also noted that longer hospital stays raised CDI risk. Lead investigator Michael Williams, PharmD, pointed out concerns about antibiotic resistance and microbiome changes. However, the study supports OVP as a useful prevention method for CDI in ASCT patients and possibly others with weakened immune systems. Further studies, including randomized trials, are needed to improve treatment guidelines and explore other applications.

Biktarvy Shows Long-Term Efficacy and Safety in HIV/HBV Coinfection After Three Years

An analysis from the ALLIANCE Phase III study presented at the 2024 HIV Glasgow Conference confirmed Biktarvy’s long-term effectiveness for adults with HIV/HBV co-infection. After three years, Biktarvy maintained high rates of HIV-1 RNA suppression (99%) and HBV DNA suppression (80.2%) at Week 144. The results showed better Hepatitis B suppression compared to TDF-based treatments, with quicker rates of HBeAg seroconversion and ALT normalization. Principal investigator Dr. Anchalee Avihingsanon noted that Biktarvy was well-tolerated. About 32% of patients experienced mild to moderate side effects, and only 1% stopped treatment due to adverse events. These findings highlight Biktarvy’s promise for long-term HIV/HBV treatment, though more research is needed for patients with severe liver issues. Early antiretroviral therapy (ART) is crucial for the best outcomes in co-infected patients.

Preventing Foodborne Illness: A Closer Look at the Recent E. coli Outbreak

Dr. Nicole M. Iovine discussed the risks of E. coli O121 related to an outbreak involving organic carrots from Grimmway Farms. This strain can lead to serious health issues like kidney failure. Dr. Iovine pointed out that organic farming practices, including compost and manure use, can contribute to food contamination. While organic farming avoids chemical pesticides, poor manure management may introduce harmful pathogens. She stressed the importance of food safety practices, such as washing produce and good hand hygiene, especially for vulnerable groups like children, the elderly, and immunocompromised individuals. Vigilance in food handling is necessary to prevent illness.

Climate Change Responsible for 19% of Today’s Rising Dengue Incidence Rates

A study presented at the 2024 American Society of Tropical Medicine and Hygiene meeting reveals that climate change contributes to rising dengue disease rates. Led by Erin Mordecai from Stanford University, the research indicates that increasing temperatures are tied to dengue outbreaks, with climate change behind 19% of current cases. The study warns of a projected 40%-60% rise in global dengue cases over the next 25 years, with significant increases in regions like Peru, Brazil, and Mexico. New areas, including parts of the U.S., may also face increased risk. The study calls for better surveillance and public health strategies to counter dengue’s increasing threat.

7-Day Antibiotic Regimen Found Noninferior to 14-Day Treatment for Bloodstream Infections

The BALANCE trial determined that a 7-day antibiotic regimen for bloodstream infections is as effective as the standard 14-day treatment, showing no significant difference in 90-day mortality. This large study included over 3,600 patients across 74 hospitals. The findings suggest that shorter treatment durations can cut healthcare costs, reduce antimicrobial resistance, and serve as a good option for critically ill patients. Despite some non-adherence, the study supports using a 7-day course as a viable alternative to longer regimens, aligning with antibiotic stewardship initiatives.